Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.

China is among the largest suppliers of ingredients used in generic drugs ... blood pressure-lowering drugs such as valsartan and losartan were removed from the market because they contained ...

This resulted in additional recalls of Valsartan, and losartan-containing products ... impairments to manufacturing quality or active ingredients can cause serious, even life-threatening adverse ...

Effective 1st February, 2021 the Life Science Ingredients business demerged from ... During the year 2022, the Company voluntarily withdrew Losartan and Losartan HCTZ product from the US market ...

The Food and Drug Administration (FDA) has approved Arbli™, an oral suspension formulation of losartan potassium. Arbli, an angiotensin II receptor blocker, is indicated for the treatment of ...